The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-(4-(2-chlorobenzylidene)-2-(4-chlorophenyl)-5-oxo-4,5-dihydro-1H-imidazol-1-yl)benzenesulfonamide ID: ALA4520818
PubChem CID: 126842939
Max Phase: Preclinical
Molecular Formula: C22H15Cl2N3O3S
Molecular Weight: 472.35
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: NS(=O)(=O)c1ccc(N2C(=O)/C(=C\c3ccccc3Cl)N=C2c2ccc(Cl)cc2)cc1
Standard InChI: InChI=1S/C22H15Cl2N3O3S/c23-16-7-5-14(6-8-16)21-26-20(13-15-3-1-2-4-19(15)24)22(28)27(21)17-9-11-18(12-10-17)31(25,29)30/h1-13H,(H2,25,29,30)/b20-13+
Standard InChI Key: VWRFFXRMUHACGT-DEDYPNTBSA-N
Molfile:
RDKit 2D
31 34 0 0 0 0 0 0 0 0999 V2000
22.3572 -3.3637 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.1467 -4.1561 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
22.9382 -3.9422 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.6273 -3.7273 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6232 -4.5445 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.3991 -4.8009 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8829 -4.1422 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.4058 -3.4787 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.6968 -4.1451 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1013 -4.8565 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.9177 -4.8609 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.3307 -4.1548 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.9212 -3.4426 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1061 -3.4417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6484 -5.5752 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0968 -6.1797 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3448 -6.9575 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.1440 -7.1321 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.6948 -6.5227 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.4439 -5.7472 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3936 -7.9102 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
16.9687 -3.2436 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0582 -2.4313 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8084 -2.1053 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8982 -1.2938 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2391 -0.8093 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4880 -1.1420 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4018 -1.9525 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6548 -2.2837 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
18.6622 -2.7028 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.5538 -4.8670 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 1 0
5 6 2 0
6 7 1 0
7 8 1 0
8 4 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 9 1 0
7 9 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 15 1 0
6 15 1 0
18 21 1 0
4 22 2 0
22 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 27 1 0
27 28 2 0
28 23 1 0
28 29 1 0
8 30 2 0
12 2 1 0
2 31 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 472.35Molecular Weight (Monoisotopic): 471.0211AlogP: 4.48#Rotatable Bonds: 4Polar Surface Area: 92.83Molecular Species: NEUTRALHBA: 4HBD: 1#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 10.13CX Basic pKa: ┄CX LogP: 4.57CX LogD: 4.57Aromatic Rings: 3Heavy Atoms: 31QED Weighted: 0.57Np Likeness Score: -1.60
References 1. Fang WY, Ravindar L, Rakesh KP, Manukumar HM, Shantharam CS, Alharbi NS, Qin HL.. (2019) Synthetic approaches and pharmaceutical applications of chloro-containing molecules for drug discovery: A critical review., 173 [PMID:30995567 ] [10.1016/j.ejmech.2019.03.063 ]